Grant: Operating Grant: ECI grants in Maternal, Reproductive, Child & Youth Health
University of Calgary
$70,000.00
Identification of biomarkers for antenatal depression in early pregnancy and associations with Child developmental milestone achievement at 12 and 24 months of age in the All Our Families prospective cohort
FY 2018-19
Summary
Antenatal depression (AD) is one of the most common pregnancy complications in developed countries. It affects about 17% of pregnancies, translating to nearly 68,000 Canadian women per year. AD is a debilitating disease for mothers, and has negative impacts on the fetus, and later infant development. The reason that AD negatively impacts infant development is not well understood. There is increasing evidence that depression coincides with inflammation in the body, and specifically elevated blood-levels of cytokines, chemicals involved in immune response. Research over the past two decades has established that inflammatory responses in the body during pregnancy, cytokines in particular, can cause damage to the brain of the developing fetus. While elevated blood-cytokines are well-documented in depressive disorders generally, similar cytokine patterns in AD are not as clear. In pregnancy, a fine immuno-regulatory balance is required to ensure the fetus is not rejected, while allowing for adequate maternal immune response to protect against infection. Normal cytokine balances thus differ in pregnancy, when compared with non-pregnant women. Little is known about healthy cytokine balances in pregnancy, making comparisons of healthy and disease-specific cytokine profiles difficult. Past studies using traditional analysis methods have been limited to comparing a small number of cytokine levels. Advanced analysis methods can identify complex patterns of cytokines and provide more information about their association with infant development. Our study will A) use advanced analysis methods to identify complex patterns of up to 43 cytokines associated with AD in early pregnancy, and B) examine associations with Infant development at 1 and 2 years of age, in a population-based prospective cohort. Our results will inform the mechanisms by which AD impacts infant development, and inform potential anti-inflammatory treatments during pregnancy to reduce negative impacts on infants.
Department
Program
Operating Grant: ECI grants in Maternal, Reproductive, Child & Youth Health
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
385825
Name
Chaput Kathleen H
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Operating Grant: New Investigator Grants in Maternal, Reproductive, Child & Youth Health
Projecttitle
Identification of biomarkers for antenatal depression in early pregnancy and associations with Child developmental milestone achievement at 12 and 24 months of age in the All Our Families prospective cohort
Programtype2
Operating Grants
Orgnameinp2
University of Calgary
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Operating Grant: ECI grants in Maternal, Reproductive, Child & Youth Health
Keyworddelim
Antenatal Depression; Cart Analysis; Cytokines; Infant Development; Inflammation; Machine-Learning
Abstract
Antenatal depression (AD) is one of the most common pregnancy complications in developed countries. It affects about 17% of pregnancies, translating to nearly 68,000 Canadian women per year. AD is a debilitating disease for mothers, and has negative impacts on the fetus, and later infant development. The reason that AD negatively impacts infant development is not well understood. There is increasing evidence that depression coincides with inflammation in the body, and specifically elevated blood-levels of cytokines, chemicals involved in immune response. Research over the past two decades has established that inflammatory responses in the body during pregnancy, cytokines in particular, can cause damage to the brain of the developing fetus. While elevated blood-cytokines are well-documented in depressive disorders generally, similar cytokine patterns in AD are not as clear. In pregnancy, a fine immuno-regulatory balance is required to ensure the fetus is not rejected, while allowing for adequate maternal immune response to protect against infection. Normal cytokine balances thus differ in pregnancy, when compared with non-pregnant women. Little is known about healthy cytokine balances in pregnancy, making comparisons of healthy and disease-specific cytokine profiles difficult. Past studies using traditional analysis methods have been limited to comparing a small number of cytokine levels. Advanced analysis methods can identify complex patterns of cytokines and provide more information about their association with infant development. Our study will A) use advanced analysis methods to identify complex patterns of up to 43 cytokines associated with AD in early pregnancy, and B) examine associations with Infant development at 1 and 2 years of age, in a population-based prospective cohort. Our results will inform the mechanisms by which AD impacts infant development, and inform potential anti-inflammatory treatments during pregnancy to reduce negative impacts on infants.
Competitiondate
201805
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Chaput, Kathleen H
Approvedterm
2 ans 0 mois
Cihrcontribution2
Inst of Human Dev &Child &Yth~ $62,812~ $0~Inst of Neurosc Mental Hlth &A~ $7,188~ $0~